Business Context and Reporting Period
On August 23, 2023, SANUWAVE Health, Inc. (SANUWAVE) filed a Form 8-K to report the entry into a definitive Merger Agreement with SEP Acquisition Corp. (SEPA), a Delaware corporation. The transaction is structured as a business combination where a wholly-owned subsidiary of SEPA will merge with and into SANUWAVE, with SANUWAVE surviving as a wholly-owned subsidiary of SEPA.
Key Financial Metrics and Transaction Terms
This filing details the terms of a proposed merger rather than reporting periodic financial performance metrics such as revenue, profit, or cash flow. Key financial terms of the transaction include:
- Merger Consideration: Holders of SANUWAVE common stock, options, warrants, and convertible promissory notes will collectively receive 7,793,000 shares of SEPA Class A Common Stock.
- Conversion Mechanics: Outstanding convertible notes, options, and warrants will be assumed by SEPA and converted into SEPA securities based on a defined Conversion Ratio.
- Liquidity Requirement: A condition to closing requires SEPA to have at least $12,000,000 in cash and cash equivalents at closing, comprising funds from the trust account (post-redemptions) and proceeds from a Private Investment in Public Equity (PIPE) investment.
- Termination Fee: SANUWAVE is obligated to pay SEPA a termination fee of $2,500,000 under specific circumstances, including the approval of a superior proposal or a change in board recommendation.
Material Changes and Conditions
The filing represents a material change in corporate structure pending the consummation of the merger. The transaction is subject to several material conditions, including:
- Approval by stockholders of both SANUWAVE and SEPA.
- SEC declaration of effectiveness for the Form S-4 registration statement.
- Listing approval of SEPA Class A Common Stock on Nasdaq.
- Conversion of at least 80% of SANUWAVE's outstanding convertible notes and warrants into common stock immediately prior to closing.
- Charter amendments by SEPA to adjust the Class B to Class A conversion ratio to 1:0.277 and remove the $5,000,000 net tangible asset requirement for redeeming offering shares.
Outlook, Risks, and Management Commentary
Management has entered into ancillary agreements to support the transaction, including Voting Agreements with certain SANUWAVE stockholders and the SEPA Sponsor to vote in favor of the merger, and Lock-Up Agreements restricting the sale of SEPA securities by SANUWAVE stockholders for 180 days post-closing.
Risks and Contingencies:
- Termination Deadlines: The agreement may be terminated if conditions are not satisfied or waived by February 28, 2024.
- Regulatory and Listing Risks: Failure to obtain necessary regulatory approvals or Nasdaq listing approval could prevent closing.
- Forward-Looking Statements: The filing cautions that actual results may differ from expectations due to risks such as the inability to consummate the transaction, delays in regulatory approvals, and changes in economic conditions.
- Trust Account Waiver: SANUWAVE has waived any claim to funds in SEPA's trust account other than in connection with the closing.
Investor Verification Checklist
- Verify the status of the Form S-4 registration statement and proxy statement filings with the SEC.
- Confirm the progress of the PIPE investment and whether the $12,000,000 cash condition at closing is achievable.
- Monitor the voting results of both SANUWAVE and SEPA stockholders regarding the merger approval.
- Check for any updates on the conversion status of the 80% threshold for convertible notes and warrants.
- Review the definitive proxy statement for detailed risk factors and the specific Conversion Ratio calculation.